Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant decline in its stock today, contrasting with the overall market's positive performance. Despite a recent weekly gain, the company's year-to-date and annual performances reflect substantial declines, raising concerns about its ongoing underperformance relative to market benchmarks.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant increase on July 17, 2026, contrasting with a decline in the broader market. Over the past week and month, the stock has outperformed the Shanghai Composite, despite facing long-term challenges reflected in its one-year and three-year performance metrics.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a notable rise in its stock today, contrasting with a decline in the broader market. Despite recent short-term gains, the company has faced significant long-term challenges, with substantial declines over the past year and year-to-date, raising concerns about its market position.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant increase today, contrasting with the decline of the China Shanghai Composite. Despite recent modest gains, the company faces long-term challenges, including substantial declines over the past year. It maintains a strong market capitalization and notable financial metrics within the sector.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant increase today, reaching an intraday high. Over the past week, the stock has performed well compared to the broader market. However, it has faced long-term challenges, with notable declines over the past month and year-to-date, alongside key financial metrics reflecting its market position.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with gains in the broader market. The company has struggled over various time frames, with notable year-to-date and annual losses. Financial metrics indicate a high valuation, while its market position remains challenging in the pharmaceuticals sector.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant intraday gain, contrasting with its long-term challenges, including a substantial one-year decline. The company, categorized as large-cap in the pharmaceuticals sector, has a market capitalization of CNY 71,867 million and notable financial metrics, including a price-to-earnings ratio of 38.00.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. faced a decline in stock value, reaching an intraday low amid ongoing market challenges. The company has underperformed significantly year-to-date and over the past year compared to the broader market, with high valuation metrics and a modest dividend yield.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a significant increase today, contrasting with a decline in the China Shanghai Composite. While the stock has gained over the past week, its longer-term performance shows a decrease in both monthly and year-to-date metrics, alongside notable challenges over the past year.

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. saw a notable increase in its stock price today, reaching an intraday high. Despite recent gains, the company has faced challenges over the past year, with significant declines compared to the broader market. It maintains a substantial market capitalization and offers a dividend yield.